Patents
Patents for C07C 219 - Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton (3,521)
04/2010
04/15/2010US20100093671 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
04/08/2010WO2009122303A3 Novel mandelate salt of fesoterodine
03/2010
03/30/2010CA2572508C One pot synthesis of 2-oxazolidinone derivatives
03/25/2010WO2009122429A3 Crystalline oxybutynin and process for preparing the same
03/18/2010WO2010010309A3 Method for the synthesis of bioresourced acrylic acid esters
03/11/2010WO2010026119A1 (meth)acrylate monomer, polymer, and coating agent
03/11/2010DE102008046075A1 (Meth)acrylatmonomer, Polymer sowie Beschichtungsmittel (Meth) acrylate monomer, polymer, and coating agent
03/11/2010CA2735880A1 (meth)acrylate monomer, polymer and coating agent
03/04/2010WO2009151712A3 Substituted phenylcyclohexylglycolates
02/2010
02/25/2010WO2009132740A3 Reactive ionic liquids
02/23/2010US7667069 ointment or eyedrops; addition of maleic acid, dissolved in a suitable organic solvent, to ibopamine base
01/2010
01/28/2010WO2010010464A2 Fesoterodine substantially free of dehydroxy impurity
01/21/2010WO2008107797A3 Lercanidipine hydrochloride polymorphs and an improved process for preparation of 1,1,n-trimethyl-n-(3,3-diphenylpropyl)-2-aminoethyl acetoacetate
01/12/2010CA2387675C Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
12/2009
12/31/2009US20090326228 Compositions containing ionic liquids and their uses, in particular in organic synthesis
12/31/2009US20090325930 Selective estrogen receptor modulator
12/30/2009EP2137134A1 Process for making a (meth) acrylamide monomer
12/29/2009US7638118 But-2-enedioic acid 2-(2-dimethylamino-ethoxy)-ethyl ester ethyl ester; but-2-enedioic acid bis-[2-(2-dimethylamino-ethoxy)-ethyl]ester; 3-[bis-(3-dimethylamino-propyl)-carbamoyl]-acrylic acid ethyl ester; deodorant or an antiperspirant
12/23/2009WO2009154208A1 Liquid-crystal alignment material, liquid-crystal display element employing same, and novel diamine
12/17/2009WO2009151712A2 Substituted phenylcyclohexylglycolates
12/17/2009WO2009151613A1 Oxybutynin derivatives
12/10/2009WO2009147057A1 Polymerizable type ii photoinitiators and curable compositions
12/09/2009EP2130817A1 Polymerizable Type II photoinitiators and curable compositions
12/09/2009CN101600785A Non-rinse fabric softener
12/03/2009WO2009112703A8 2-amino-2-phenylalkanol derivatives, preparation thereof and pharmaceutical compositions containing same
12/02/2009EP2125697A1 Positively charged water-soluble prodrugs of retinoids and retinoid-like compounds with very high skin penetration rates
12/02/2009CN100564351C Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it
11/2009
11/25/2009EP2123627A1 Process for producing aromatic amine having aralkyloxy or heteroaralkyloxy group
11/25/2009EP2121887A1 Non-rinse fabric softener
11/25/2009EP2121576A1 Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
11/25/2009EP2121575A2 Lercanidipine hydrochloride polymorphs and an improved process for preparation of 1,1,n-trimethyl-n-(3,3-diphenylpropyl)-2-aminoethyl acetoacetate
11/18/2009EP2118050A2 Aminoalcohol derivatives and their therapeutic use
11/18/2009CN100560548C Synthesis process of 18F labeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst
11/11/2009CN101575299A Method for synthesizing dual-long-chain ester based quaternary ammonium salt
11/11/2009CN100558409C Thiotungstate analogues and uses thereof
11/03/2009US7612114 Selective estrogen receptor modulator
10/2009
10/28/2009EP2111223A1 Amine derivative compounds for treating ophthalmic diseases and disorders
10/22/2009WO2009129387A2 Cationic lipids and uses thereof
10/21/2009CN101563395A Polyimide, diamine compound and method for producing the same
10/21/2009CN100551902C Photoactive materials
10/08/2009WO2009122429A2 Crystalline oxybutynin and process for preparing the same
10/08/2009US20090253930 Manufacture of Esters
09/2009
09/30/2009CN101544572A Ambroxol derivative and method for preparing same
09/17/2009WO2009112703A1 2-amino-2-phenylalkanol derivatives, preparation thereof and pharmaceutical compositions containing same
09/17/2009CA2712489A1 2-amino-2-phenyl-alkanol derivatives, their preparation and pharmaceutical compositions containing them
09/16/2009EP2099739A1 Method for the synthesis of (meth)acrylic esters catalysed by a polyol titanate.
09/08/2009CA2478066C Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
09/08/2009CA2292017C Substituted cycloheptenes, their preparation and use
09/01/2009CA2262063C Tool holder module for anode extraction and transfer in an aluminum plant and facility operating such a module
08/2009
08/26/2009EP1981958B1 Fabric conditioning compositions
08/26/2009CN100531732C Thiomolybdate analogues
08/19/2009EP2089110A2 Acetylene derivatives and their use for binding and imaging amyloid plaques
08/19/2009CN100528834C Pharmaceutical compounds
07/2009
07/30/2009WO2009092523A1 Compositions for road construction
07/29/2009EP2083050A1 Compositions for road contruction
07/23/2009WO2009090791A1 Process for producing quaternary salt of dialkylaminoalkyl (meth)acrylate
07/22/2009CN101489986A Salts of trimebutine and N-desmethyl trimebutine
07/16/2009WO2009087804A1 Process for production of dialkylaminoalkyl (meth)acrylate
07/16/2009WO2009037569A3 An improved process for the preparation of fesoterodine
07/15/2009EP1663948B1 Process for the preparation of (meth)acrylate di-ammonium salts and their use as monomers for the synthesis of polymers
07/09/2009WO2009067491A3 Derivatized tertiary amines and uses thereof
07/08/2009EP2076485A2 Process for making aminoalkylphenyl carbamates and intermediates therefor
07/02/2009US20090170941 Pharmaceutical Compounds
06/2009
06/18/2009US20090156653 such as 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentane-1-ol, used for treating autoimmune diseases, rheumatoid arthritis, psoriasis, dermatitis, asthma, hay fever or rejection of organ or bone morrow transplantation; side effect reduction
06/11/2009US20090149444 Benzylamine analogues
06/04/2009US20090143467 Anticancer agents based on regulation of protein prenylation
05/2009
05/28/2009WO2009067491A2 Derivatized tertiary amines and uses thereof
05/27/2009CN100491336C Novel derivatives of 3,3-diphenylpropylamines
05/26/2009CA2464223C Quarternary ammonium compounds and their use as antimuscarinic agents
05/21/2009US20090131535 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
05/13/2009EP2057139A1 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
05/07/2009WO2009037707A3 N-phenyl anthranilic acid derivatives and uses thereof
05/05/2009CA2233064C Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin:polynucleotide transfection complexes
04/2009
04/30/2009WO2009054545A1 Liquid crystal aligning agent, method for forming liquid crystal alignment film and liquid crystal display device
04/28/2009US7524887 use of 2-(phenylalkyl)-substituted 2-amino-1,3-propanediols such as 2-amino-2-[2-(4-heptylphenyl)ethyl]-1,3-propanediol to treat chronic pain such as that associated with AIDs, chemotherapy, tumors, back pain; sphingosine-1-phosphate (SIP)-receptor agonists
04/23/2009WO2009018389A4 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same
04/22/2009EP2049464A1 Preparation of 3-ý(1r,2r)-3-(dimethylamino)-1ethyl-2-methylpropyl¨phenol
04/22/2009CN101412681A Method for preparing 3-(2-dimethyl aminomethyl-cyclohexyl)-phenol acetic ester hydrochloride
04/16/2009WO2009047905A1 Acylation reaction of hydroxyl group
04/16/2009WO2003082205A3 Compounds and methods
04/16/2009CA2700111A1 Acylation reaction of hydroxyl group
04/09/2009WO2009044278A1 Amorphous fesoterodine fumarate
04/08/2009CN101402611A Compound with anti-leukocythemia liveness and method of preparing the same
04/08/2009CN101402575A Flame-retardant compound, flame-retardant particle, resin composition and resin formed body
04/08/2009CN101402562A Novel benzophenone derivatives or salts thereof
04/08/2009CN100475773C Synthesis method of naphthalene disulfonic acid aclatonium and similar compound thereof
04/07/2009US7514475 Benzylamine analogues
04/02/2009WO2009042013A1 Process for the synthesis of e1 activating enzyme inhibitors
04/02/2009CA2695193A1 Process for the synthesis of e1 activating enzyme inhibitors
03/2009
03/31/2009CA2389749C Stable salts of novel derivatives of 3,3-diphenylpropylamines
03/26/2009WO2009037707A2 N-phenyl anthranilic acid derivatives and uses thereof
03/26/2009WO2009014829A3 Methods for introducing reactive secondary amines pendant to polymer backbones that are useful for diazeniumdiolation
03/25/2009EP2038251A1 Positively charged water-soluble prodrugs of aspirin
03/25/2009EP2038250A2 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
03/24/2009US7507859 Quaternary ammonium compound having ester and/or amide groups; cationic amphiphilic molecule or macromolecule that transforms from a cationic entity to an anionic, neutral, or zwitterionic entity by a chemical, photochemical, or biological reaction and its use for delivery of nucleic acids
03/18/2009EP2035367A1 Ship 1 modulator prodrugs
03/17/2009US7504437 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants
03/17/2009US7504432 Quaternary salt of (3-((2-(3,3-difluorocyclopentyl)-2-hydroxy-2-(4-methylphenyl)ethanoyl)oxy)-1,1-dimethylpyrrolidinium bromide; respiratory system disorders; chronic obstructive pulmonary diseases, bronchitis, asthma, emphysema, rhinitis; side effect reduction; inhalants; muscarinic receptor antagonists
03/17/2009US7504393 Benzylamine analogues
03/11/2009EP2032522A1 Shortened synthesis using paraformaldehyde or trioxane
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 36